Search results
Results From The WOW.Com Content Network
The European pharmaceutical industry was worth $283 billion in 2020, and from then until 2028 it will grow at a compounded annual growth rate (CAGR) of 5.4% to sit at $432 billion by the end of ...
Among continents, European countries sold the highest dollar value worth of exported drugs and medicines during 2018 with shipments from Europe totaling $295.8 billion or 79.70% of the global total. In second place were Asian pharmaceutical exporters at 10.70% while 8.10% of worldwide drugs and medicine shipments originated from North America.
The pharmaceutical industry is a medical industry that discovers, develops, produces, and markets pharmaceutical goods such as medications and medical devices. Medications are then administered to (or self-administered by) patients for curing or preventing disease or for alleviating symptoms of illness or injury.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association and lobbying organisation, founded in 1978 and representing the pharmaceutical industry operating in Europe.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
UK Pharmaceutical employment of 73,000 in 2017 [4] compares to 114,000 as of 2015 in Germany, [5] 92,000 as of 2014 in France [6] and 723,000 in the European Union as a whole. [6] In the United States 281,440 people worked in the pharmaceutical industry as of 2016.
70% of the investments in life sciences in Europe are made in the United Kingdom, Germany, Ireland, the Netherlands, France, and Switzerland. [ 4 ] [ 5 ] In addition to pharmaceutical companies (65 companies), Switzerland is home to many companies in the fields of biotechnology (338 companies) or medical devices and technology (341 companies).